A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Concord Repatriation General Hospital, Concord, New South Wales, Australia
Contact: Study coordinator (Eunji Lee) · Eunji.lee2@health.nsw.gov.au · +61 02 9767 6820
Neuroscience Research Australia, Randwick, New South Wales, Australia
Contact: Study coordinator (Eleanor Ramsey) · clinicaneurology@neura.edu.au · +62 02 9399 1146
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Contact: Study coordinator (Susan Heggie) · Susan.Heggie@health.qld.gov.au · (07) 3646 0016
Flinders Medical Centre, Bedford Park, South Australia, Australia
Contact: Study coordinator (Karalyn Ernst) · karalyn.ernst@sa.gov.au · +62 08 8204 5712
Calvery Health care Bethlehem, Caulfield South, Victoria, Australia
Contact: Study coordinator (Yana Wu) · yana.wu@calvarycare.org.au · 6195953294
Perron Institute, Nedlands, Western Australia, Australia
Contact: Study coordinator (Ruby Shehatha) · ruby.shehatha@perron.uwa.edu.au · 61864570213
Stan Cassidy Center for Rehabilitation, Fredericton, New Brunswick, Canada
Contact: Study coordinator (Shane McCullum) · Shane.a.mccullum@horizonnb.ca · (506) 447-4379
Genge Partners, Montreal, Quebec, Canada
Contact: Study coordinator (Kevin Munoz) · kmunoz@gpresearchinc.com · +1 514-906-3876 ext. 6026

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · La Jolla, United States

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Lübeck, Germany · Milan, Italy

Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE2

San Giovanni Rotondo, Italy · Novara, Italy

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Sebastián, Spain